Premier Veterinary logo

PVG - Premier Veterinary Share Price

30.5p 0.5  1.7%

Last Trade - 14/08/20

Sector
Healthcare
Size
Micro Cap
Market Cap £4.60m
Enterprise Value £8.60m
Revenue £3.96m
Position in Universe 1655th / 1816
Bullish
Bearish
Unlock PVG Revenue
Momentum
Relative Strength (%)
1m -14.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -53.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 2.25 1.87 2.53 3.15 3.86 8.00 10.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 March 2020, Premier Veterinary Group PLC revenues increased 5% to £2M. Net loss decreased 25% to £1.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other administrative expenses decrease of 17% to £2.6M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -£0.10 to -£0.08.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PVG
Graphical History

Revenue

PVG Revenue Unlock PVG Revenue

Net Income

PVG Net Income Unlock PVG Revenue

Normalised EPS

PVG Normalised EPS Unlock PVG Revenue

PE Ratio Range

PVG PE Ratio Range Unlock PVG Revenue

Dividend Yield Range

PVG Dividend Yield Range Unlock PVG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PVG EPS Forecasts Unlock PVG Revenue
Profile Summary

Premier Veterinary Group plc, formerly Ark Therapeutics Group plc, operates various veterinary practices and provides non-medical services to other veterinary practices. The Company operates through segments, including Vets Business, Pet Care Plan and Pet Care Plan overseas. The Vets Business segment is engaged in day to day running of veterinary practices. Its Pet Care Plan is the fees received for the collection and management of direct debits on behalf of veterinary practices external to the Company. The Company's Pet Care Plan is divided into the United Kingdom and overseas. The Company, through its subsidiary, Premier Vet Alliance Limited (PVA), is a provider of services to veterinary practices, including the administration of a preventative healthcare program for pets branded Pet Care Plan.

Directors
Last Annual September 30th, 2019
Last Interim March 31st, 2020
Incorporated October 31, 2001
Public Since March 8, 2004
No. of Shareholders: n/a
No. of Employees: 40
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange London Stock Exchange (AIM)
Shares in Issue 15,346,950
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PVG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PVG
Upcoming Events for PVG
Frequently Asked Questions for Premier Veterinary
What is the Premier Veterinary share price?

As of 14/08/20, shares in Premier Veterinary are trading at 30.5p, giving the company a market capitalisation of £4.60m. This share price information is delayed by 15 minutes.

How has the Premier Veterinary share price performed this year?

Shares in Premier Veterinary are currently trading at 30.5p and the price has moved by -48.72% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Premier Veterinary price has moved by -42.49% over the past year.

What are the analyst and broker recommendations for Premier Veterinary?

Of the analysts with advisory recommendations for Premier Veterinary, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Premier Veterinary is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Premier Veterinary next release its financial results?

Premier Veterinary is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Premier Veterinary dividend yield?

Premier Veterinary does not currently pay a dividend.

Does Premier Veterinary pay a dividend?

Premier Veterinary does not currently pay a dividend.

When does Premier Veterinary next pay dividends?

Premier Veterinary does not currently pay a dividend.

How do I buy Premier Veterinary shares?

To buy shares in Premier Veterinary you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Premier Veterinary?

Shares in Premier Veterinary are currently trading at 30.5p, giving the company a market capitalisation of £4.60m.

Where are Premier Veterinary shares listed? Where are Premier Veterinary shares listed?

Here are the trading details for Premier Veterinary:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: PVG
What kind of share is Premier Veterinary?

Based on an overall assessment of its quality, value and momentum, Premier Veterinary is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Premier Veterinary share price forecast 2020?

Shares in Premier Veterinary are currently priced at 30.5p. At that level they are trading at 0.167% discount to the analyst consensus target price of 30.55.

Analysts covering Premier Veterinary currently have a consensus Earnings Per Share (EPS) forecast of -0.033 for the next financial year.

How can I tell whether the Premier Veterinary share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Premier Veterinary. Over the past six months, the relative strength of its shares against the market has been -8.63%. At the current price of 30.5p, shares in Premier Veterinary are trading at -28.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Premier Veterinary PE Ratio?

We were not able to find PE ratio data for Premier Veterinary.

Who are the key directors of Premier Veterinary?

Premier Veterinary's management team is headed by:

Susan Margaret Steven - SEC
Dominic Tonner - CEO
Rajan Uppal - EDR
Graham Dick - NEC
Neil Wood - NID
Andy Paull - CFO
Who are the major shareholders of Premier Veterinary?

Here are the top five shareholders of Premier Veterinary based on the size of their shareholding:

Uppal (Rajan) Individual Investor
Percentage owned: 35.32% (5.42m shares)
Somerset-Leeke (Michael Fitzroy) Individual Investor
Percentage owned: 15.02% (2.31m shares)
Tonner (Dominic Stephen) Individual Investor
Percentage owned: 11.73% (1.80m shares)
Investec Wealth & Investment Limited Investment Advisor
Percentage owned: 0.33% (50.0k shares)
Ark Therapeutics Group Employee Benefit Trust Corporation
Percentage owned: 0.27% (41.1k shares)
Similar to PVG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.